Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases.

Andrei Nikiforchin Vadim Gushchin Michelle Sittig Ekaterina Baron Mary Caitlin King Carol Nieroda Armando Sardi

Published in: Annals of surgical oncology (2021)

DR during CRS/HIPEC does not increase morbidity and mortality. It is associated with worse survival in appendiceal and colorectal tumors, even after adjusting for tumor burden but does not appear to impact ovarian cancer survival.

Keyphrases

minimally invasive
free survival
low grade
coronary artery bypass
coronary artery disease
surgical site infection
percutaneous coronary intervention
metastatic renal cell carcinoma
rectal cancer
chemotherapy induced